In Utero Exposure to Cancer Treatment

LISA SCHULMEISTER, RN, MN, APRN-BC, OCN, FAAN
Thursday, December 04, 2014
Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Little is known about outcomes when cancer treatment occurs during pregnancy. Although women starting chemotherapy and/or radiotherapy are routinely advised to use birth control during treatment, some women already are pregnant or become pregnant during treatment. In two studies presented at the 2014 European Society for Medical Oncology meeting by Frederic Amant, MD, from the University Hospitals Leuven in Belgium, findings suggest that treatment during pregnancy does not appear to negatively impact neurologic or cardiac fetal development.

In the first study, 38 children exposed to chemotherapy in utero were recruited from the International Network for Cancer, Infertility and Pregnancy (INCIP) registry and assessed for mental development and cardiac health. Their outcomes were compared to 38 children who were not exposed to chemotherapy and served as the control group. At a median age of almost two, mental development (measured by the Mental Development Index) was in the normal range for both groups of children, and were not significantly different. Cardiac dimensions and functions were within normal ranges for both groups.

In the second study, Amant explored the impact of radiotherapy on the children of women with cancer. The study included 16 children and 10 adults who had been exposed to radiotherapy in utero. This is the first long-term follow-up study of children prenatally exposed to medical radiation, and findings suggest that neuropsychological, behavioral and general health outcomes for those exposed to radiotherapy were within normal ranges. One child had a severe cognitive delay; however; other pregnancy-related complications were confounding factors. The researchers concluded that this knowledge about outcomes may assist clinicians in counselling patients who are pregnant, or become pregnant, during treatment. More information is available here.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
 
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
 
 
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.